NCT02550002View on ClinicalTrials.gov

Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2022

Study Completion Date

August 31, 2022

Conditions
Age Related Macular Degeneration
Interventions
DRUG

Aflibercept

Intravitreal injection

Trial Locations (2)

3010

Department of Ophthalmology, University Hospital Bern, Bern

Inselspital Bern, Department of Ophthalmology, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02550002 - Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen | Biotech Hunter | Biotech Hunter